Barclays’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1M Sell
600,014
-163,832
-21% -$2.75M ﹤0.01% 1155
2025
Q1
$11.7M Buy
763,846
+440,350
+136% +$6.77M ﹤0.01% 929
2024
Q4
$7.13M Sell
323,496
-104,099
-24% -$2.29M ﹤0.01% 1339
2024
Q3
$7.71M Buy
427,595
+102,848
+32% +$1.85M ﹤0.01% 1199
2024
Q2
$5.28M Sell
324,747
-373,257
-53% -$6.06M ﹤0.01% 1144
2024
Q1
$9.85M Sell
698,004
-303,177
-30% -$4.28M ﹤0.01% 1038
2023
Q4
$10.5M Sell
1,001,181
-117,021
-10% -$1.22M ﹤0.01% 1033
2023
Q3
$11.4M Buy
1,118,202
+69,502
+7% +$709K 0.01% 839
2023
Q2
$7.9M Sell
1,048,700
-736,245
-41% -$5.54M 0.01% 992
2023
Q1
$15.8M Buy
1,784,945
+782,101
+78% +$6.92M 0.01% 670
2022
Q4
$9.15M Buy
1,002,844
+128,177
+15% +$1.17M ﹤0.01% 861
2022
Q3
$7.06M Buy
874,667
+262,338
+43% +$2.12M 0.01% 939
2022
Q2
$4.6M Buy
612,329
+216,984
+55% +$1.63M ﹤0.01% 1156
2022
Q1
$3.71M Sell
395,345
-750,574
-65% -$7.05M ﹤0.01% 1341
2021
Q4
$9.18M Sell
1,145,919
-199,367
-15% -$1.6M ﹤0.01% 926
2021
Q3
$13.1M Sell
1,345,286
-74,233
-5% -$723K 0.01% 815
2021
Q2
$14.1M Buy
1,419,519
+607,253
+75% +$6.01M 0.01% 801
2021
Q1
$9.37M Sell
812,266
-59,505
-7% -$687K 0.01% 860
2020
Q4
$8.41M Buy
871,771
+104,286
+14% +$1.01M ﹤0.01% 826
2020
Q3
$6.92M Buy
767,485
+42,394
+6% +$382K ﹤0.01% 836
2020
Q2
$8.94M Sell
725,091
-623,149
-46% -$7.68M 0.01% 709
2020
Q1
$12.1M Sell
1,348,240
-1,228,884
-48% -$11M 0.01% 552
2019
Q4
$25.3M Buy
2,577,124
+1,403,587
+120% +$13.8M 0.01% 543
2019
Q3
$8.07M Sell
1,173,537
-371,900
-24% -$2.56M 0.01% 870
2019
Q2
$14.3M Buy
1,545,437
+304,293
+25% +$2.81M 0.01% 705
2019
Q1
$19.5M Buy
1,241,144
+20,190
+2% +$317K 0.01% 553
2018
Q4
$18.8M Sell
1,220,954
-152,778
-11% -$2.36M 0.01% 502
2018
Q3
$29.6M Buy
1,373,732
+288,537
+27% +$6.21M 0.02% 425
2018
Q2
$26.4M Sell
1,085,195
-186,006
-15% -$4.52M 0.02% 413
2018
Q1
$21.7M Sell
1,271,201
-1,255,294
-50% -$21.5M 0.02% 536
2017
Q4
$47.9M Buy
2,526,495
+1,028,094
+69% +$19.5M 0.04% 276
2017
Q3
$26.4M Buy
1,498,401
+216,317
+17% +$3.81M 0.03% 311
2017
Q2
$42.6M Sell
1,282,084
-440,865
-26% -$14.6M 0.05% 194
2017
Q1
$55.3M Buy
1,722,949
+596,713
+53% +$19.1M 0.06% 142
2016
Q4
$40.8M Buy
1,126,236
+662,482
+143% +$24M 0.04% 183
2016
Q3
$21.3M Sell
463,754
-2,723,181
-85% -$125M 0.02% 280
2016
Q2
$160M Buy
3,186,935
+2,311,490
+264% +$116M 0.21% 32
2016
Q1
$46.4M Buy
875,445
+115,072
+15% +$6.1M 0.07% 138
2015
Q4
$49.4M Sell
760,373
-52,748
-6% -$3.43M 0.06% 150
2015
Q3
$45.5M Sell
813,121
-103,881
-11% -$5.82M 0.05% 152
2015
Q2
$54.1M Buy
917,002
+265,226
+41% +$15.6M 0.06% 148
2015
Q1
$40.4M Sell
651,776
-46,101
-7% -$2.86M 0.05% 234
2014
Q4
$39.8M Sell
697,877
-762,887
-52% -$43.5M 0.04% 232
2014
Q3
$77.4M Buy
1,460,764
+208,823
+17% +$11.1M 0.07% 119
2014
Q2
$65.1M Sell
1,251,941
-702,852
-36% -$36.5M 0.07% 142
2014
Q1
$102M Buy
1,954,793
+438,332
+29% +$22.8M 0.12% 89
2013
Q4
$60.7M Buy
1,516,461
+333,728
+28% +$13.3M 0.06% 167
2013
Q3
$43.8M Buy
1,182,733
+365,119
+45% +$13.5M 0.05% 188
2013
Q2
$32.1M Buy
+817,614
New +$32.1M 0.04% 226